| abstract |
The invention relates to monoclonal antibodies or antigen binding fragments thereof that specifically bind to human GFR3, and to methods for using them. In some embodiments, the antibodies are fully human antibodies that bind to human GFR3. Antibodies in accordance with the present invention are useful for treating diseases associated with one or more biological activities of GFR3, including for treating conditions of acute or chronic pain. |